Long QT syndrome and associated gene mutation carriers in Japanese children: results from ECG screening examinations

Size: px
Start display at page:

Download "Long QT syndrome and associated gene mutation carriers in Japanese children: results from ECG screening examinations"

Transcription

1 Clinical Science (2009) 117, (Printed in Great Britain) doi: /cs Long QT syndrome and associated gene mutation carriers in Japanese children: results from ECG screening examinations Kenshi HAYASHI, Noboru FUJINO, Katsuharu UCHIYAMA, Hidekazu INO, Kenji SAKATA, Tetsuo KONNO, Eiichi MASUTA, Akira FUNADA, Yuichiro SAKAMOTO, Toshinari TSUBOKAWA, Keisuke NAKASHIMA,LiLIU, Haruhiro HIGASHIDA, Yoshitake HIRAMARU, Masami SHIMIZU and Masakazu YAMAGISHI Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science, 13-1, Takara-machi, Kanazawa, Ishikawa , Japan, Department of Biophysical Genetics, Kanazawa University Graduate School of Medical Science, 13-1, Takara-machi, Kanazawa, Ishikawa , Japan, and Cardiovascular Checkup Committee for School Pupils, Kanazawa Medical Association, Kanazawa, Japan A B S T R A C T LQTS (long QT syndrome) is caused by mutations in cardiac ion channel genes; however, the prevalence of LQTS in the general population is not well known. In the present study, we prospectively estimated the prevalence of LQTS and analysed the associated mutation carriers in Japanese children. ECGs were recorded from 7961 Japanese school children (4044 males; mean age, years). ECGs were examined again for children who had prolonged QTc (corrected QT) intervals in the initial ECGs, and their QT intervals were measured manually. An LQTS score was determined according to Schwartz s criteria, and ion channel genes were analysed. In vitro characterization of the identified mutants was performed by heterologous expression experiments. Three subjects were assigned to a high probability of LQTS (3.5 LQTS score), and eight subjects to an intermediate probability (1.0< LQTS score 3.0). Genetic analysis of these II subjects identified three KCNH2 mutations (M124T, del GGCGGCG and del/ins TC). In contrast, no mutations were identified in the 15 subjects with a low probability of LQTS. Electrophysiological studies showed that both the M124T and the del GGCGGCG KCNH2 did not suppress the wild-type KCNH2 channel in a dominant-negative manner. These results demonstrate that, in a random sample of healthy Japanese children, the prevalence of a high probability of LQTS is % (three in 7961), and that LQTS mutation carriers can be identified in at least % (one in 2653). Furthermore, large-scale genetic studies will be needed to clarify the real prevalence of LQTS by gene-carrier status, as it may have been underestimated in the present study. INTRODUCTION LQTS (long QT syndrome) is an inherited disorder characterized by delayed cardiac repolarization and a possibility of lethal ventricular tachyarrhythmias, resulting in fainting spells and sudden death [1]. Mutations in various genes encoding cardiac ion channels and membrane adaptor proteins are known to cause this syndrome [2], and many LQTS mutations have been identified [3 6]. A previous study [7] has shown that approx. 36 % of patients Key words: cardiovascular screening, ion channel, long QT syndrome, molecular genetics. Abbreviations: CHO, Chinese-hamster ovary; CNBD, cyclic nucleotide-binding domain; CRBBB, complete right bundle branch block; HR, heart rate; LQTS, long QT syndrome; QTc, corrected QT; SSCP, single-strand conformation polymorphism; TEV, two-electrode voltage-clamp; WT, wild-type. Correspondence: Dr Kenshi Hayashi ( kenshi@med.kanazawa-u.ac.jp).

2 416 K. Hayashi and others with untreated genetically defined LQTS had cardiac events, such as syncope, cardiac arrest and sudden death, before the age of 40 years. That study also established that the association between genetic locus, gender and QTc (corrected QT) interval could be used to define three levels of risk of sudden death: high (> 50 %), intermediate (30 49 %) and low (< 30 %), and proposed that prophylactic treatment was warranted in patients at high and intermediate risk. In addition, a recent study [8] has demonstrated age-specific risk factors for aborted cardiac arrest or sudden cardiac death in children with LQTS. It is, therefore, important to make an early diagnosis of patients with LQTS, both clinically and genetically, and to perform a risk stratification for their management. The prevalence of LQTS in the general population is not well known. Most investigators have reported that one in every people are affected by Romano Ward syndrome, an autosomal-dominant form of LQTS [9 12]; however, these estimates were not based on actual data. To date, only two studies have determined the prevalence of LQTS or the frequency of cardiac channel mutations [13,14]. One of these studies has shown the prevalence of LQTS to be one in 1164 [13]; the other showed that the frequency of LQTS mutation carriers was at least one in 2500 [14]. In the present study, we took advantage of a cardiovascular screening programme for Japanese school children. A total of 7961 Japanese school children were screened for LQTS and, based on preliminary evidence from ECGs indicating the possible presence of LQTS, a subgroup were evaluated further. For example, we also performed genetic analysis on this subgroup of LQTS subjects for the presence of the major LQTS genes, such as KCNQ1, KCNH2, SCN5A, KCNE1 and KCNE2, and estimated the frequency of LQTS mutation carriers. MATERIALS AND METHODS Cardiovascular screening In Kanazawa city, which is representative of a major urban city in Japan, there is a cardiovascular ECG screening programme aimed at all school children in first, seventh and tenth grades to identify congenital heart problems. In accordance with this programme, ECGs were recorded in 7961 school children (4161 and 3800 in first and seventh grade respectively), and the QTc interval was automatically determined by Bazett s formula (QTc interval = QT/RR 1/2 ) as an initial cardiovascular screening. School children were also checked, during this initial screening, for clinical and familial findings associated with LQTS (i.e. syncope, congenital deafness and unexplained sudden cardiac death among family members). ECGs were recorded mainly using an ECP-7641 machine (Fukuda Denshi) at a paper speed of 25 mm/s, which automatically determined the average of the QT intervals measured from all cardiac beats during 8 s on four leads. Because the QTc interval of males is generally shorter than that of females, males were screened against different criteria. Children having a prolonged QTc interval ( 450 ms for males and 460 ms for females) and/or having abnormal clinical and familial findings were referred to the Cardiovascular Checkup Committee for School Pupils of the Kanazawa Medical Association for a re-check of their ECGs and their clinical and familial findings. This committee participated in the design of the present study and conducted secondary cardiovascular screening (see Acknowledgements section). All of these referred subjects had standard 12-lead ECGs recorded at Kanazawa University Hospital at a paper speed of 25 mm/s and at an amplification of 0.1 mv/mm. They were also asked about clinical and family history again in order to assign an LQTS score [14 16]. The ECG tracings were enlarged to twice the normal size and their measurements were carried out by two investigators, who were blinded to the subjects genetic status, clinical history and automated QTc interval values prior to making the manual measurements. QT was measured manually, and was taken as the time interval between QRS onset and the point at which the isoelectric line intersected a tangential line drawn at the maximal downslope of the positive T wave. QT interval measurements were the means of three consecutive beats at leads II, avf and V3 V5. We took the longest QT interval from one of these leads. The LQTS score was determined according to the LQTS Diagnostic Criteria [14 16]. We divided the subjects into three categories: (i) those with a score of 1 (defined as a low probability of LQTS), (ii) those with ascoreof> 1 to 3.0 (an intermediate probability), and (iii) those with a score of 3.5 (a high probability). DNA isolation and mutation analysis To determine the frequency of the gene mutation carriers in the children, we performed genetic analysis, after obtaining written informed consent from their guardians in accordance with the guidelines of the Bioethical Committee on Medical Research. We screened for mutations by PCR SSCP (single-strand conformation polymorphism) analysis, as described previously [4], in all exons of KCNQ1, KCNH2, SCN5A, KCNE1 and KCNE2. Normal and aberrant SSCP products were isolated and sequenced by ABI PRISM 310 (PerkinElmer). With respect to these mutations, we also determined whether they were present in 200 healthy controls. For the detection of deletion or insertion mutations, we performed TA cloning using the TOPO TA cloning kit (Invitrogen), and sequenced normal and mutant alleles separately. Plasmid constructs and electrophysiology KCNH2 cdna in the mammalian expression vector psi (Promega) was kindly provided by Dr Sabina Kupershmidt (Vanderbilt University School of Medicine,

3 Prevalence of long QT syndrome 417 Nashville, TN, U.S.A.). Both the M124T and the del GGCGGCG KCNH2 cdnas were constructed using an overlap extension strategy. CHO-K1 cells (where CHO is Chinese-hamster ovary; Riken BRC Cell Bank) were cultured and transiently transfected with WT (wild-type) KCNH2 (1 μg) alone, WT KCNH2 (1 μg) plus mutant KCNH2 (1 μg) and mutant KCNH2 (1 μg) alone, using FuGENE 6 TM transfection reagent (Roche). We did not use Xenopus oocytes with the TEV (two-electrode voltage-clamp) technique because the oocyte provides a non-ideal space clamp, and fast kinetic parameters that are derived from TEV measurements are not always comparable with the same parameters measured with the patch clamp technique [17]. Membrane currents were studied essentially as described previously [18]. Data acquisition and analysis were performed using a DIGIDATA 1321 A/D converter and pclamp8.2 software (Axon Instruments). The pulse protocol is shown in Figures 6 and 7, and described in the legend to Figure 6. Voltage clamp command pulses were generated, and patch clamp data were acquired using pclamp8 software (version 8.2; Axon Instruments). Data analysis was carried out using Clampfit (version 8.2; Axon Instruments). Table 1 Characteristics of the 73 school children referred to Kanazawa University Hospital following initial screening Values are means + S.E.M. P < 0.05 compared with the value at initial screening; P < 0.05 compared with the first grade at University Hospital. First grade (n = 41) Seventh grade (n = 32) Male Female Male Female Cases (n) Initial screening HR (beats/min) QTc interval (ms) University Hospital HR (beats/min) QTc interval (ms) Data analysis Values are means + S.E.M. Differences among these values were evaluated using ANOVA and unpaired Student s t tests, where appropriate. A Fisher s exact test was used to assess the hypothesis of independence between categorical variables in 2 2 tables. P < 0.05 was considered to be significant. RESULTS Cardiovascular screening From April 2004 to March 2005, a total of 7961 junior high-school students and elementary school children (4044 males; mean age, years) underwent ECG testing and were checked for clinical and familial findings associated with LQTS. Eventually, 73 of these subjects were selected for further study, due to abnormal QTc intervals and/or abnormal clinical and familial findings. None had a history of syncope, but two had a family history of unexplained sudden cardiac death below 30 years of age. At the initial cardiovascular screening, ECGs of these 73 subjects had indicated rapid but appropriate HRs (heart rates) for their respective age groups (Table 1). These ECGs also showed relatively prolonged QTc intervals, because the QTc intervals were overcorrected by Bazett s formula based on a wide range of relatively high HRs. The repeat ECGs showed significantly slower HRs compared with the initial screening (P < 0.05; Table 1), probably because of differences in the examination environment. The Figure 1 Cardiovascular screening for male (A) and female (B) school children N, numbers of children who were categorized based on the LQTS Diagnostic Criteria (Schwartz score). average QTc interval determined manually under the appropriate HR was significantly shorter than that determined under rapid HR during the initial cardiovascular screening (P < 0.05; Table 1). For males, 45 out of 4044 children were identified for further investigation based on the initial cardiovascular screening at school (Figure 1A). Of these, two were excluded because of CRBBB (complete right bundle branch block), whereas the ECGs of 43 others were reexamined. Eventually, one subject with a high probability

4 418 K. Hayashi and others Table 2 Clinical characteristics of 11 children with high and intermediate probabilities of LQTS Tpe, T wave peak-to-end interval divided by the QT interval; T peak to end, T wave peak-to-end interval. Case Age (years) Gender PR (ms) QRS (ms) QT (ms) RR (ms) QTc (ms) T peak to end (ms) Tpe LQTS score Category 1 7 Male High 2 7 Female High 3 13 Female High 4 7 Male Intermediate 5 7 Male Intermediate 6 7 Female Intermediate 7 13 Male Intermediate 8 13 Male Intermediate 9 13 Female Intermediate Female Intermediate Female Intermediate Figure 2 ECGs of three subjects with a high probability of LQTS (A) Case 1 was a 7-year-old boy with an HR of 81 beats/min and a QTc interval of 487 ms, which are the means of three consecutive beats at lead V3. Notched T waves were present at leads V3 to V4. His aunt (see Figure 3B, II-2) also had prolonged QTc intervals of 529 ms and the presence of notched T waves at leads V3 V5. The boy s final LQTS score was 4 (QTc interval 480 ms and family members with definite LQTS). (B) Case 2 was a 7-year-old girl with an HR of 74 beats/min and a QTc interval of 489 ms, which are the means of three consecutive beats at lead II. The notched T waves were identified at leads II, avf and V3 V5. Her aunt (see Figure 4B, II-2) also had a prolonged QTc interval of 510 ms and the presence of notched T waves at leads V2 V5. The LQTS score was 5 (QTc interval 480 ms and notched T wave in three leads, and family members with definite LQTS). (C) Case 3 was a 13-year-old girl with an HR of 61 beats/min and a QTc interval of 534 ms, which are the means of three consecutive beats at lead II. The notched T waves were observed at leads II, avf and V4 V6. Her LQTS score was 4(QTcinterval 480 ms and notched T wave in three leads). of LQTS (Case 1 in Table 2 and Figure 2A), four with an intermediate probability of LQTS (Table 2), and 38 with a low probability of LQTS were identified (Figure 1A). For females, 28 out of 3917 subjects were identified for further investigation based on the initial cardiovascular screening at school (Figure 1B), and the ECGs of all 28 female subjects were re-examined. Eventually, two subjects with a high probability of LQTS (Case 2 in Table 2 and Figure 2B; and Case 3 in Table 2 and Figure 2C), four with an intermediate probability of LQTS (Table 2) and 22 with a low probability of LQTS were identified. Thus, out of 7961 school children, there were three subjects (0.38 in 1000) with a high probability and eight (1.0 in 1000) with an intermediate probability (Table 2). Molecular genetic analyses and clinical characteristics of the genotyped subjects From these 73 subjects (45 boys and 28 girls) identified by the initial screening, we obtained 26 blood samples (three subjects with a high probability, eight with an intermediate probability and 15 with a low probability

5 Prevalence of long QT syndrome 419 Table 3 Mutations and polymorphisms identified in the present study G185fsX198, a frame-shift changing Gly 185 as the first affected amino acid, and the new reading frame ending in a stop at position 198. H771fsX796, a frame-shift changing His 771 as the first affected amino acid, and the new reading frame ending in a stop at position 796. Gene Nucleotide change Amino acid change Region Mutation KCNH2 T371C M124T N-terminal KCNH del GGCGGCG G185fsX198 N-terminal KCNH del/ins TC H771fsX796 CNBD Polymorphism KCNQ1 C1343G P448R C-terminal KCNQ1 G1927A G643S C-terminal SCN5A A1673G H558R DI DII KCNE1 A112G S38G Extracellular of LQTS) and screened them for mutations in the five different ion channel genes. The remaining 47 subjects, all with a low probability, did not undergo genetic testing, either because their LQTS scores were zero or because they refused consent. Genetic analyses revealed three mutations in the KCNH2 gene (Table 3): M124T in the N-terminus (Figure 3A), del/ins TC in the CNBD (cyclic nucleotide-binding domain) (Figure 4A) and del GGCGGCG in the N-terminus (Figure 5B). All three of the identified mutations were absent in the 200 healthy control subjects. Although we have reported previously on the point mutation M124T in 27- and 58-year-old females [19], the other frame-shift mutations are novel findings in the present study. The M124T mutation was identified from Case 1, who was diagnosed as having a high probability of LQTS (QTc interval 480 ms and family members with definite LQTS) (Tables 2 and 3, Figures 2A and 3). In this proband, five members of his family also carried this same mutation, of which four had prolonged QTc intervals (Figure 3B). Moreover, two of them experienced TdP (torsade de pointes), accompanied by faintness, after they had started taking probucol [19]. The del/ins TC mutation was identified in Case 2, who was diagnosed as having a high probability of LQTS (QTc interval 480 ms, notched T waves in three leads and family members with definite LQTS) (Tables 2 and 3, and Figures 2B and 4). This mutation was found in two other members of the proband pedigree (Figure 4B). The del GGCGGCG mutation was identified from another 7-year-old boy (Case 4 in Tables 2 and 3, and Figure 5), who was diagnosed as having an intermediate probability of LQTS (QTc interval ms and notched T wave in three leads). This mutation was only found in the proband and is thought to be de novo (Figure 5B). A further familial study of each detected Figure 3 Mutation analysis of the KCNH2 gene and the pedigree of Case 1 (A) DNA sequence chromatogram. (B) Pedigree and QTc intervals. The arrow in the pedigree indicates the individual with the proband, and the numbers indicate the length of the QTc interval (ms). (, ) Heterozygous male or female patients respectively, with a prolonged QTc interval and the M124T KCNH2 mutation. (C) PCR SSCP analysis. All six individuals with the M124T mutation had abnormal SSCP conformers. mutation revealed that there was no other first or seventh grade school children with the same gene mutations identified in each proband. In contrast with these highand intermediate-probability cases, no mutation was identified in the 15 subjects with a low probability of LQTS. There was a statistically significant difference in the frequency of the LQTS mutation carriers between the subjects with a high or intermediate probability and the those with a low probability (P = 0.045, as determined by a Fisher s exact test). Genetic analysis also revealed two polymorphisms in the KCNQ1 gene [P448R in one subject with a low probability and G643S in two cases (Cases 4 and 6) with an intermediate probability of LQTS]. We also found a polymorphism in the SCN5A gene [H558R in a subject (Case 10) with an intermediate probability of LQTS] and one polymorphism in the KCNE1 gene [S38G in three cases (Cases 7, 8 and 9) with an intermediate probability and eight with a low probability of LQTS] (Table 3). For Case 3, with a high probability of LQTS, we could not detect any genetic anomaly by PCR SSCP analysis. All exons and exon intron boundaries of KCNQ1, KCNH2, SCN5A, KCNE1 and KCNE2 were analysed

6 420 K. Hayashi and others Figure 4 Mutation analysis of the KCNH2 gene and the pedigree of Case 2 (A) DNA sequence chromatogram. (B) Pedigree of Case 2 and QTc intervals. The arrow in the pedigree indicates the individual with the proband, and the numbers indicate the length of the QTc interval (ms). ( ) Heterozygous female patients with a prolonged QTc interval and this mutation. Figure 5 ECG, mutation analysis of the KCNH2 gene and the pedigree of Case 4 (A) ECG of Case 4 showing prolonged QTc interval of 478 ms and notched T waves at leads II, III, avf and V3 V5. The LQTS score was 3 (QTc interval of ms and notched T wave in three leads), and he was diagnosed as having an intermediate probability of LQTS. (B) DNA sequence chromatogram. (C) Pedigree of Case 4 and QTc intervals. The arrow in the pedigree indicates the individual with the proband, and the numbers below indicate the length of the QTc interval (ms). ( ) Heterozygous male patient with a prolonged QTc interval and this mutation. by direct DNA sequence analysis, which revealed no mutations in any of these genes. Electrophysiological findings of the detected mutations We analysed the two KCNH2 mutations in cultured mammalian cells [18,20,21]. CHO-K1 cells transfected with 1.0 μg ofwtkcnh2 cdna expressed a slowly activating outward current by step depolarizations (Figures 6A and 7A). In contrast, the amplitude of the outward tail current through the M124T channels, was less than half that through the WT KCNH2 channels (Figure 6A). CHO-K1 cells transfected with 1.0 μg of del GGCGGCG KCNH2 cdna did not express functional channels at all (Figure 7A). When equal amounts of 1.0 μg ofwtkcnh2 cdna and 1.0 μg of M124T or del GGCGGCG KCNH2 cdna (i.e. 2.0 μg of cdna in total) were transfected into CHO-K1 cells, the evoked currents were approximately the same as those in CHO-K1 cells transfected with 1.0 μgofwtkcnh2 cdna alone (Figures 6A and 7A). The current voltage relationships for activating peak currents and tail currents were recorded during depolarizing pulses (Figures 6B and 6C, and Figures 7B and 7C). The mean amplitude of the tail currents measured at 50 mv, after a depolarizing test pulse of + 40 mv, was pa/pf (n = 13) for the M124T KCNH2 channels, which was significantly smaller than pa/pf (n = 13) for the WT KCNH2 channels (Figure 6C). The mean amplitude for the M124T + WT KCNH2 channels were pa/pf (n = 13), which were comparable with that of the WT KCNH2 channels. The mean amplitude of the tail currents was pa/pf (n = 5) for the del GGCGGCG KCNH2 channels, pa/pf (n = 11) for the WT KCNH2 channels, and pa/pf (n = 13) for the del GGCGGCG + WT KCNH2 channels (Figure 7C). These results suggest that both mutant KCNH2 channels did not have dominant-negative effects.

7 Prevalence of long QT syndrome 421 Figure 6 Functional characterization of M124T KCNH2 in CHO-K1 cells (A) Representative expressed currents in CHO-K1 cells transfected with 1 μg ofwtkcnh2 alone (upper trace), 1 μg of M124T KCNH2 alone (middle trace) and 1 μg ofwtkcnh2 + 1 μg of M124T KCNH2 (lower trace). Depolarizing pulses were applied from a holding potential of 80 mv to various potentials between 60 mv and + 60 mv in 10 mv increments for 2 s, followed by a hyperpolarizing pulse to 50 mv for 2 s. (B) and (C) Current voltage relationships for peak (B) and tail (C) currents in CHO-K1 cells transfected with WT KCNH2 alone, M124T KCNH2 alone and WT KCNH2 + M124T KCNH2. P < 0.05 compared with WT KCNH2. The n values indicate the number of CHO-K1 cells examined. Figure 7 Functional characterization of del GGCGGCG KCNH2 in CHO-K1 cells (A) Representative expressed currents in CHO-K1 cells transfected with 1 μg ofwtkcnh2 alone (upper trace), 1 μg of del KCNH2 alone (middle trace) and 1 μg ofwtkcnh2 + 1 μg of del GGCGGCG KCNH2 (lower trace). (B) and (C) Current voltage relationships for peak (B) and tail (C) currents in CHO-K1 cells transfected with WT KCNH2 alone, del GGCGGCG KCNH2 alone and WT KCNH del GGCGGCG KCNH2. Then values indicate the number of CHO-K1 cells examined. P < 0.05 and P < 0.01 compared with WT KCNH2.

8 422 K. Hayashi and others DISCUSSION Prevalence of LQTS estimated from cardiovascular screening The present study provides evidence that three out of 7961 healthy Japanese children have a high probability of LQTS. Previous reviews have estimated the prevalence of Romano Ward syndrome, the autosomal-dominant form of LQTS, as one in [9 12]. One review also indicated that 40 % of patients with LQTS were asymptomatic at diagnosis [9]. In the present study, we evaluated the ECGs of a large number of school children and diagnosed those patients with LQTS. It should be noted that none of the children had any past history of cardiac events at diagnosis. A previous study has determined the prevalence of LQTS in 4655 Japanese children by measuring three consecutive QT and RR intervals [13]. That study showed the prevalence of non-familial LQTS to be four in 4655 (i.e. one in 1164), which is slightly higher than the prevalence of LQTS found in the present study. This difference may arise from the different diagnostic criteria for LQTS used in the two studies. We diagnosed LQTS on the basis of the LQTS Diagnostic Criteria described by Schwartz and co-workers [14 16], whereas the previous study [13] based the final diagnosis of LQTS in accordance with different criteria. A recent prospective study, which examined the ECGs of infants at 3 4 weeks of age, demonstrated that the frequency of LQTS gene mutation carriers was at least one in 2500 [14], which is almost the same as that found in the present study. Consequently, it is possible that the prevalence of LQTS is higher than supposed previously. In the present study, we identified gene mutations in three out of 11 subjects with a high or intermediate probability of LQTS. Two of the three mutations were identified from subjects with a high probability of LQTS and one from a subject with intermediate probability. In contrast, no mutations were identified in the 15 subjects with a low probability of LQTS, which suggests that this is less frequently associated with gene mutations. Clinical characteristics and risk stratification of the children with LQTS in the present study We clinically diagnosed three subjects (Cases 1 3) as having a high probability of LQTS (Figure 2 and Table 2), and identified three mutations in the KCNH2 gene [M124T in Case 1 (Figure 3), del/ins TC in Case 2 (Figure 4), and del GGCGGCG in Case 4 (Figure 5)]. According to a previous study [7], it is thought that female subjects with KCNH2 mutations have a high or an intermediate risk of a first cardiac event before 40 years of age. Therefore female subjects with a KCNH2 mutation, such as Case 2 in our present study, should be treated prophylactically with β-blockers. In contrast, the male subjects with a QTc interval of < 500 ms and having a KCNH2 mutation, such as Case 1 and Case 4 in the present study, are thought to have a risk of a first cardiac event before 40 years of age of < 30 %. A recent study [8], regarding age-specific risk factors for life-threatening cardiac events, identified male gender as a predictor of these events in genotyped children with LQTS [8]. Therefore β-blockers should be initiated in these two cases to reduce aborted cardiac arrest or sudden cardiac death during childhood. For Case 3, who had a significant prolonged QTc interval of 534 ms, we were unable to identify any major LQTS gene mutation. Despite this, we consider that Case 3 is at high risk of sudden cardiac death and should be treated with β-blockers, since a QTc interval 500 ms identifies subjects with the highest risk of becoming symptomatic by 40 years of age [7,22]. The therapeutic strategy for the rest of the children (Cases 5 11) in our present study, who were asymptomatic, with a QTc interval 500 ms, and had no evidence of gene mutation, is controversial. It should be noted that male subjects experience a significantly higher rate of lifethreatening cardiac events during childhood (5 %) than female subjects (1 %) [8]. Careful consideration should be given to the debate on whether such male subjects (Cases 5, 7 and 8) should be treated with β-blockers or not, including discussion with their guardians. They should be referred for serial follow-up ECGs [23], exercise ECG testing and 24-h Holter monitoring [24]. Of course, lifestyle modification and the avoidance of drugs known to prolong the QT interval are essential for all 11 cases. Electrophysiological study In our present study, we characterized the electrophysiological properties of recombinant KCNH2 channels engineered with two mutations (M124T and del GGCGGCG) identified in the Japanese children. M124T KCNH2 generated much smaller, but similar, currents compared with WT KCNH2 (Figure 6). The del GGCGGCG KCNH2 generated no current at all (Figure 7), suggesting that this mutant protein may be either unstable or does not reach the plasma membrane [25]. Neither KCNH2 channel mutant had a dominant-negative effect on the WT KCNH2 channel. Most mutations in the pore regions of KCNH2 are missense mutations with dominant-negative effects on I Kr (delayed rectifying K + channel), whereas most mutations in the non-pore regions of KCNH2 are associated with co-assembly or trafficking abnormalities, resulting in haplotype insufficiency [26,27]. M124T KCNH2 is obviously not a pore mutation, and del GGCGGCG KCNH2 would probably not be expected to traffic normally and, hence, exert a dominantnegative effect [28]. Under these conditions, however, both mutations were associated with a decrease in co-expressed currents. These results may explain, in part,

9 Prevalence of long QT syndrome 423 the clinical findings showing moderate QT prolongation and no incidence of cardiac events in the absence of environmental stressor even with gene mutations [29]. Study limitations There remain several limitations of the present study. First, the QT interval was determined using an automatic method in the initial cardiovascular screening of 7961 school children. However, it has been reported recently that manual and automated measurements of QT intervals generated similar results in healthy volunteers, and that automated techniques have a clear utility in extensive QT studies in healthy volunteers [30]. Secondly, the PCR SSCP method is not completely sensitive enough for mutational screening. Therefore we performed a direct DNA sequence analysis on one patient with a high probability and negative for the SSCP method for all exons and exon intron boundaries of the major LQTS genes. Thirdly, we did not analyse the del/ins TC KCNH2 because we expected this del/ins KCNH2 to have similar electrophysiological properties to the del GGCGGCG KCNH2, taking into account a previous study which showed that the protein encoded by the deletions of KCNH2 did not form functional channels and did not have a dominant-negative effect on WT KCNH2 function [28]. Finally, the true prevalence of LQTS by gene carrier status could be an underestimation, because we did not perform a genetic analysis in all 7961 subjects. LQTS may cause sudden infant death and, therefore, it is quite probable that some candidates had died before they reached the age selected for screening in the present study. Conclusions The present study demonstrates that both the prevalence of LQTS and the incidence of LQTS mutation carriers is higher than previous estimates [9 12], although the prevalence of LQTS by gene carrier status has not yet been established. We suggest genetic analysis is performed on all subjects who are diagnosed as having an intermediate risk of LQTS, as well as those with a high probability, even if they are asymptomatic. ACKNOWLEDGEMENTS We thank the members of the Cardiovascular Checkup Committee for School Pupils of the Kanazawa Medical Association (Yoshitake Hiramaru, Kenichi Doniwa, Shigeru Ichibayashi, Hideki Irimichi, Minoru Kubo, Munetoshi Matoba, Masato Morita, Yuichi Murata, Tatsumi Nagata, Jun Ogawa, Kunio Ohta, Takashi Ohno, Tsutomu Okamoto, Shinobu Sakazume, Kiyoshi Sato, Masami Shimizu, Yukichi Suzuki, Kentaro Takahashi, Yozo Tsugawa, Yutaka Wakasa and Toru Yokoi). FUNDING This work was supported in part by grants from Miyata Cardiology Research Promotion Funds, and the Ministry of Health, Labour and Welfare of Japan. REFERENCES 1 Moss, A. J., Schwartz, P. J., Crampton, R. S., Tzivoni, D., Locati, E. H., Maccluer, J., Hall, W. J., Weitkamp, L., Vincent, G. M., Garson, Jr, A. et al. (1991) The long QT syndrome. Prospective longitudinal study of 328 families. Circulation 84, Roden, D. M. (2008) Long-QT syndrome. N. Engl. J. Med. 358, Hayashi, K., Shimizu, M., Ino, H., Okeie, K., Yamaguchi, M., Yasuda, T., Fujino, N., Fujii, H., Fujita, S. and Mabuchi, H. (2000) Identical twins with long QT syndrome associated with a missense mutation in the S4 region of the HERG. Jpn Heart J. 41, Hayashi, K., Shimizu, M., Ino, H., Yamaguchi, M., Mabuchi, H., Hoshi, N. and Higashida, H. (2002) Characterization of a novel missense mutation E637K in the pore-s6 loop of HERG in a patient with long QT syndrome. Cardiovasc. Res. 54, Yamaguchi, M., Shimizu, M., Ino, H., Terai, H., Hayashi, K., Mabuchi, H., Hoshi, N. and Higashida, H. (2003) Clinical and electrophysiological characterization of a novel mutation (F193L) in the KCNQ1 gene associated with long QT syndrome. Clin. Sci. 104, Yamaguchi, M., Shimizu, M., Ino, H., Terai, H., Hayashi, K., Kaneda, T., Mabuchi, H., Sumita, R., Oshima, T., Hoshi, N. and Higashida, H. (2005) Compound heterozygosity for mutations Asp611 Tyr in KCNQ1 and Asp609 Gly in KCNH2 associated with severe long QT syndrome. Clin. Sci. 108, Priori, S. G., Schwartz, P. J., Napolitano, C., Bloise, R., Ronchetti, E., Grillo, M., Vicentini, A., Spazzolini, C., Nastoli, J., Bottelli, G. et al. (2003) Risk stratification in the long-qt syndrome. N. Engl. J. Med. 348, Goldenberg, I., Moss, A. J., Peterson, D. R., Mcnitt, S., Zareba, W., Andrews, M. L., Robinson, J. L., Locati, E. H., Ackerman, M. J., Benhorin, J. et al. (2008) Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-qt syndrome. Circulation 117, Ackerman, M. J. (1998) The long QT syndrome: ion channel diseases of the heart. Mayo Clin. Proc. 73, Chiang, C. E. and Roden, D. M. (2000) The long QT syndromes: genetic basis and clinical implications. J. Am. Coll. Cardiol. 36, Schwartz, P. J. (1997) The long QT syndrome. Curr. Probl. Cardiol. 22, Zupancic, J. A., Triedman, J. K., Alexander, M., Walsh, E. P., Richardson, D. K. and Berul, C. I. (2000) Cost-effectiveness and implications of newborn screening for prolongation of QT interval for the prevention of sudden infant death syndrome. J. Pediatr. 136, Fukushige, T., Yoshinaga, M., Shimago, A., Nishi, J., Kono, Y., Nomura, Y., Miyata, K., Imamura, M., Shibata, T., Nagashima, M. and Niimura, I. (2002) Effect of age and overweight on the QT interval and the prevalence of long QT syndrome in children. Am. J. Cardiol. 89, Crotti, L., Celano, G., Dagradi, F. and Schwartz, P. J. (2008) Congenital long QT syndrome. Orphanet. J. Rare Dis. 3, Schwartz, P. J., Moss, A. J., Vincent, G. M. and Crampton, R. S. (1993) Diagnostic criteria for the long QT syndrome: an update. Circulation 88, Schwartz, P. J. (2006) The congenital long QT syndromes from genotype to phenotype: clinical implications. J. Intern. Med. 259, Pusch, M. (2006) Analysis of electrophysiological data. In Expression and Analysis of Recombinant Ion Channels: from Structural Studies to Pharmacological Screening (Clare, J. J. and Trezise, D. J., eds), pp , Wiley, New York

10 424 K. Hayashi and others 18 Kupershmidt, S., Yang, I. C., Hayashi, K., Wei, J., Chanthaphaychith, S., Petersen, C. I., Johns, D. C., George, Jr, A. L., Roden, D. M. and Balser, J. R. (2003) The IKr drug response is modulated by KCR1 in transfected cardiac and noncardiac cell lines. FASEB J. 17, Hayashi, K., Shimizu, M., Ino, H., Yamaguchi, M., Terai, H., Hoshi, N., Higashida, H., Terashima, N., Uno, Y., Kanaya, H. and Mabuchi, H. (2004) Probucol aggravates long QT syndrome associated with a novel missense mutation M124T in the N-terminus of HERG. Clin. Sci. 107, Nakajima, T., Hayashi, K., Viswanathan, P. C., Kim, M. Y., Anghelescu, M., Barksdale, K. A., Shuai, W., Balser, J. R. and Kupershmidt, S. (2007) HERG is protected from pharmacological block by α-1,2-glucosyltransferase function. J. Biol. Chem. 282, Petersen, C. I., Mcfarland, T. R., Stepanovic, S. Z., Yang, P., Reiner, D. J., Hayashi, K., George, A. L., Roden, D. M., Thomas, J. H. and Balser, J. R. (2004) In vivo identification of genes that modify ether-a-go-go-related gene activity in Caenorhabditis elegans may also affect human cardiac arrhythmia. Proc. Natl. Acad. Sci. U.S.A. 101, Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J. et al. (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Circulation 114, e385 e Goldenberg, I., Mathew, J., Moss, A. J., McNitt, S., Peterson, D. R., Zareba, W., Benhorin, J., Zhang, L., Vincent, G. M., Andrews, M. L. et al. (2006) Corrected QT variability in serial electrocardiograms in long QT syndrome: the importance of the maximum corrected QT for risk stratification. J. Am. Coll. Cardiol. 48, Goldenberg, I., Zareba, W. and Moss, A. J. (2008) Long QT Syndrome. Curr. Probl. Cardiol. 33, Gong, Q., Zhang, L., Vincent, G. M., Horne, B. D. and Zhou, Z. (2007) Nonsense mutations in herg cause a decrease in mutant mrna transcripts by nonsensemediated mrna decay in human long-qt syndrome. Circulation 116, January, C. T., Gong, Q. and Zhou, Z. (2000) Long QT syndrome: cellular basis and arrhythmia mechanism in LQT2. J. Cardiovasc. Electrophysiol. 11, Sakamoto, Y., Ino, H, Fujino, N, Uchiyama, K, Hayashi, K, Sakata, K, Masuta, E, Funada, A., Tsubokawa, T., Nakasima, K. et al. (2006) Mutations in the nonpore region of the HERG gene are at risk of acquired long QT syndrome. Circulation 116, II Sanguinetti, M. C., Curran, M. E., Spector, P. S. and Keating, M. T. (1996) Spectrum of HERG K + -channel dysfunction in an inherited cardiac arrhythmia. Proc. Natl. Acad. Sci. U.S.A. 93, Yang, P., Kanki, H., Drolet, B., Yang, T., Wei, J., Viswanathan, P. C., Hohnloser, S. H., Shimizu, W., Schwartz, P. J., Stanton, M. et al. (2002) Allelic variants in long-qt disease genes in patients with drug-associated torsades de pointes. Circulation 105, Darpo, B., Agin, M., Kazierad, D. J., Layton, G., Muirhead, G., Gray, P. and Jorkasky, D. K. (2006) Man versus machine: is there an optimal method for QT measurements in thorough QT studies? J. Clin. Pharmacol. 46, Received 15 October 2008/23 March 2009; accepted 16 April 2009 Published as Immediate Publication 16 April 2009, doi: /cs

Diagnostic Scoring System for LQTS

Diagnostic Scoring System for LQTS Medical Coverage Policy Genetic Testing: Congenital Long QT Syndrome Device/Equipment Drug Medical Surgery Test Other Effective Date: 2/15/2011 Policy Last Updated: 2/21/2012 Prospective review is recommended/required.

More information

The long-qt syndrome (LQTS) is an inherited or acquired

The long-qt syndrome (LQTS) is an inherited or acquired Compound Mutations A Common Cause of Severe Long-QT Syndrome Peter Westenskow, BS; Igor Splawski, PhD; Katherine W. Timothy, BS; Mark T. Keating, MD; Michael C. Sanguinetti, PhD Background Long QT syndrome

More information

Long QT. Long QT Syndrome. A Guide for

Long QT. Long QT Syndrome. A Guide for Long QT Long QT Syndrome A Guide for Introduction Long QT syndrome (LQTS) is a genetic heart disorder due to the malfunction of cardiac ion channels that results in 4,000 deaths annually in the United

More information

Genetic Long QT Syndrome GENETIC TESTING FOR LONG QT SYNDROME HS-148. Policy Number: HS-148. Original Effective Date: 1/21/2010

Genetic Long QT Syndrome GENETIC TESTING FOR LONG QT SYNDROME HS-148. Policy Number: HS-148. Original Effective Date: 1/21/2010 Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance

More information

Risk Stratification in the Long-QT Syndrome

Risk Stratification in the Long-QT Syndrome The new england journal of medicine original article Risk Stratification in the Long-QT Syndrome Silvia G. Priori, M.D., Ph.D., Peter J. Schwartz, M.D., Carlo Napolitano, M.D., Ph.D., Raffaella Bloise,

More information

Previously Published Works UC San Francisco

Previously Published Works UC San Francisco Previously Published Works UC San Francisco A University of California author or department has made this article openly available. Thanks to the Academic Senate s Open Access Policy, a great many UC-authored

More information

By Theresa A. Beery, RN, PhD, ACNP, Kerry A. Shooner, MS, CGC, and D. Woodrow Benson, MD, PhD

By Theresa A. Beery, RN, PhD, ACNP, Kerry A. Shooner, MS, CGC, and D. Woodrow Benson, MD, PhD Cases of Note Cases of Note features peer-reviewed case reports and case series that document clinically relevant findings from critical and high acuity care environments. Cases that illuminate clinical

More information

January 14-15, 2011 SCA Conference 2

January 14-15, 2011 SCA Conference 2 Electrical Abnormalities: Long QT and Beyond Yaniv Bar-Cohen, M.D. Assistant Professor of Pediatrics Division of Cardiology / Electrophysiology Childrens Hospital Los Angeles Keck School of Medicine Genetic

More information

Investigation of Ion Channel Gene Variants in Patients with Long QT Syndrome

Investigation of Ion Channel Gene Variants in Patients with Long QT Syndrome Investigation of Ion Channel Gene Variants in Patients with Long QT Syndrome Ernesto Curty 1, Fernando Eugênio dos Santos Cruz 2, Fabiane Santos Lima 1, Jorge Luiz Albuquerque Coutinho 2, Rosane Silva

More information

Long QT syndrome! Should we treat all asymptomatic patients?!

Long QT syndrome! Should we treat all asymptomatic patients?! ! Long QT syndrome! Should we treat all asymptomatic patients?! Venice Arrhythmia 2015! Arthur A.M. Wilde Heart Centre NO CONFLICT OF INTEREST TO DECLARE Long QT Syndrome(s) Autosomal dominant/autosomal

More information

Long-QT syndrome (LQTS) is a cardiovascular disorder

Long-QT syndrome (LQTS) is a cardiovascular disorder Spectrum of Mutations in Long-QT Syndrome Genes KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 Igor Splawski, PhD; Jiaxiang Shen, MS; Katherine W. Timothy, BS; Michael H. Lehmann, MD; Silvia Priori, MD, PhD; Jennifer

More information

A Case of Long QT Syndrome Type 3 Aggravated by Beta-Blockers and Alleviated by Mexiletine: The Role of Epinephrine Provocation Test

A Case of Long QT Syndrome Type 3 Aggravated by Beta-Blockers and Alleviated by Mexiletine: The Role of Epinephrine Provocation Test Case Report http://dx.doi.org/10.3349/ymj.2013.54.2.529 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 54(2):529-533, 2013 A Case of Long QT Syndrome Type 3 Aggravated by Beta-Blockers and Alleviated

More information

Usefulness of Epinephrine Test in the Congenital Long QT Syndrome

Usefulness of Epinephrine Test in the Congenital Long QT Syndrome Usefulness of Epinephrine Test in the Congenital Long QT Syndrome Wataru Shimizu M.D., Ph.D. CASE PRESENTATION A 14-year old Japanese boy was successfully resuscitated from cardiac arrest (near drowning)

More information

Long-QT Syndrome. The Cl inic a l Problem

Long-QT Syndrome. The Cl inic a l Problem T h e n e w e ng l a nd j o u r na l o f m e dic i n e clinical practice Long-QT Syndrome Dan M. Roden, M.D. This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Testing for Cardiac Ion Channelopathies File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_cardiac_ion_channelopathies 10/2008 4/2015

More information

Application for a Marketing Authorisation: Requirements and Criteria for the Assessment of QT Prolonging Potential

Application for a Marketing Authorisation: Requirements and Criteria for the Assessment of QT Prolonging Potential Application for a Marketing Authorisation: Requirements and Criteria for the Assessment of QT Prolonging Potential Bundesinstitut für Arzneimittel Dr. med. Clemens Mittmann Bundesinstitut für Arzneimittel

More information

Electrocardiographic Issues in Williams Syndrome

Electrocardiographic Issues in Williams Syndrome Electrocardiographic Issues in Williams Syndrome R. Thomas Collins II, MD Assistant Professor, Pediatrics and Internal Medicine University of Arkansas for Medical Sciences Arkansas Children s Hospital

More information

Life Threatening EKG s In The Office. Joseph A Manfredi, MD, FACC, FHRS GHS Cardiovascular Symposium

Life Threatening EKG s In The Office. Joseph A Manfredi, MD, FACC, FHRS GHS Cardiovascular Symposium Life Threatening EKG s In The Office Joseph A Manfredi, MD, FACC, FHRS GHS Cardiovascular Symposium January 24 th, 2015 Disclosures Speaker Honorariums: STJM, Boston Scientific Advisory role: Medtronic

More information

Genetic Testing in the Long QT Syndrome

Genetic Testing in the Long QT Syndrome ORIGINAL CONTRIBUTION Genetic Testing in the Long QT Syndrome Development and Validation of an Efficient Approach to Genotyping in Clinical Practice Carlo Napolitano, MD, PhD Silvia G. Priori, MD, PhD

More information

Overview of Inherited Heart Rhythm Disorders for Patients

Overview of Inherited Heart Rhythm Disorders for Patients Introduction Overview of Inherited Heart Rhythm Disorders for Patients Inherited heart rhythm disorders affect a small portion of the population, presenting as palpitations, fainting, heart arrest and

More information

How to read the ECG in athletes: distinguishing normal form abnormal

How to read the ECG in athletes: distinguishing normal form abnormal How to read the ECG in athletes: distinguishing normal form abnormal Antonio Pelliccia, MD Institute of Sport Medicine and Science www.antoniopelliccia.it Cardiac adaptations to Rowing Vagotonia Sinus

More information

Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome

Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome James P. Daubert, MD, Wojciech Zareba, MD, PhD, Spencer Z. Rosero, MD, Adam Budzikowski, MD, PhD, Jennifer L. Robinson,

More information

Guidelines for the diagnosis and management of Familial Long QT Syndrome

Guidelines for the diagnosis and management of Familial Long QT Syndrome The Cardiac Society of Australia and New Zealand Guidelines for the diagnosis and management of Familial Long QT Syndrome These guidelines were revised by Dr Jonathan Skinner and a members of the Cardiovascular

More information

NEONATAL & PEDIATRIC ECG BASICS RHYTHM INTERPRETATION

NEONATAL & PEDIATRIC ECG BASICS RHYTHM INTERPRETATION NEONATAL & PEDIATRIC ECG BASICS & RHYTHM INTERPRETATION VIKAS KOHLI MD FAAP FACC SENIOR CONSULATANT PEDIATRIC CARDIOLOGY APOLLO HOSPITAL MOB: 9891362233 ECG FAX LINE: 011-26941746 THE BASICS: GRAPH PAPER

More information

Sudden Arrhythmia Death Syndrome: Importance of the Long QT Syndrome

Sudden Arrhythmia Death Syndrome: Importance of the Long QT Syndrome Sudden Arrhythmia Death Syndrome: Importance of the Long QT Syndrome JOHN S. MEYER, M.D., St. Luke s Hospital, Chesterfield, Missouri ALI MEHDIRAD, M.D., Midwest Heart Rhythm, St. Louis, Missouri BAKR

More information

Long QT Syndrome Genetic Testing for Inherited Arrhythmias. patient guide

Long QT Syndrome Genetic Testing for Inherited Arrhythmias. patient guide Long QT Syndrome Genetic Testing for Inherited Arrhythmias patient guide What is Long QT Syndrome? Arrhythmias are problems with the electrical system in the heart that controls the heartbeat s regular

More information

Acquired, Drug-Induced Long QT Syndrome

Acquired, Drug-Induced Long QT Syndrome Acquired, Drug-Induced Long QT Syndrome A Guide for Patients and Health Care Providers Sudden Arrhythmia Death Syndromes (SADS) Foundation 508 E. South Temple, Suite 202 Salt Lake City, Utah 84102 800-STOP

More information

The QT interval: Too long, too short or just right

The QT interval: Too long, too short or just right CONTEMPORARY REVIEW The QT interval: Too long, too short or just right Sami Viskin, MD From Tel-Aviv Sourasky Medical Center, Sackler-School of Medicine, Tel Aviv, Israel. The hallmark of the congenital

More information

Clinical Science (2006) 110, 125 131 (Printed in Great Britain) doi:10.1042/cs20050189 125

Clinical Science (2006) 110, 125 131 (Printed in Great Britain) doi:10.1042/cs20050189 125 Clinical Science (2006) 110, 125 131 (Printed in Great Britain) doi:10.1042/cs20050189 125 A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with

More information

National Medical Policy

National Medical Policy National Medical Policy Subject: Policy Number: Genetic Testing for Long QT Syndrome NMP490 Effective Date*: February 2005 Updated: August 2015 This National Medical Policy is subject to the terms in the

More information

QT analysis: A guide for statistical programmers. Prabhakar Munkampalli Statistical Analyst II Hyderabad, 7 th September 2012

QT analysis: A guide for statistical programmers. Prabhakar Munkampalli Statistical Analyst II Hyderabad, 7 th September 2012 QT analysis: A guide for statistical programmers Prabhakar Munkampalli Statistical Analyst II Hyderabad, 7 th September 2012 Agenda ECG ICH E14 Thorough QT/QTc study Role of Statistical Programmer References

More information

REVIEW ARTICLES BACKGROUND

REVIEW ARTICLES BACKGROUND Journal of the American College of Cardiology Vol. 36, No. 1, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00716-6 REVIEW

More information

Long QT syndrome: from channels to cardiac arrhythmias

Long QT syndrome: from channels to cardiac arrhythmias Review series Long QT syndrome: from channels to cardiac arrhythmias Arthur J. Moss 1 and Robert S. Kass 2 1 Heart Research Follow-up Program, Department of Medicine, University of Rochester School of

More information

sudden cardiac death, torsades de pointes, T wave alternans, syncope, genetic mutation

sudden cardiac death, torsades de pointes, T wave alternans, syncope, genetic mutation Reprinted with permission from JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY Volume 12 No. 4 April 2001 Copyright 2001 by Futura Publishing Company Inc. Armonk NY 10504-0418 Electrocardiographic Prediction

More information

Polymorphisms in the NOS1AP Gene Modulate QT Interval Duration and Risk of Arrhythmias in the Long QT Syndrome

Polymorphisms in the NOS1AP Gene Modulate QT Interval Duration and Risk of Arrhythmias in the Long QT Syndrome Journal of the American College of Cardiology Vol. 55, No. 24, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.12.065

More information

Clinical Perspective. Molecular genetics of inherited long QT syndromes. The long QT syndrome. Introduction. Clinical aspects/diagnostic criteria

Clinical Perspective. Molecular genetics of inherited long QT syndromes. The long QT syndrome. Introduction. Clinical aspects/diagnostic criteria European Heart Journal (1998) 19, 1427 1433 Article No. hj980873 Clinical Perspective Molecular genetics of inherited long QT syndromes Introduction Unravelling the molecular cause of QT prolongation is

More information

Innovation Platform: Sudden Cardiac Death

Innovation Platform: Sudden Cardiac Death Innovation Platform: Sudden Cardiac Death Prof. dr. Bart Loeys CRC Antwerp General Assembly VzW Board of Directors Strategic Advisory Board Staff: 1 executive director 1 ICT manager 1 financial administration

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S7B

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE S7B INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE THE NON-CLINICAL EVALUATION OF THE POTENTIAL FOR

More information

Cardiopatie Aritmogene nel Giovane

Cardiopatie Aritmogene nel Giovane Firenze, 16 Novembre 2012 Cardiopatie Aritmogene nel Giovane Prof. Luigi Padeletti Università degli Studi di Firenze 1) Long QT Syndrome 2) Short QT Syndrome 3) J wave Syndrome: Early Repolarization Syndrome

More information

Electrocardiography Review and the Normal EKG Response to Exercise

Electrocardiography Review and the Normal EKG Response to Exercise Electrocardiography Review and the Normal EKG Response to Exercise Cardiac Anatomy Electrical Pathways in the Heart Which valves are the a-v valves? Closure of the a-v valves is associated with which heart

More information

Medical Policy Manual. Topic: Genetic Testing for Cardiac Ion Channelopathies Date of Origin: December 2012

Medical Policy Manual. Topic: Genetic Testing for Cardiac Ion Channelopathies Date of Origin: December 2012 Medical Policy Manual Topic: Genetic Testing for Cardiac Ion Channelopathies Date of Origin: December 2012 Section: Genetic Testing Last Reviewed Date: December 2015 Policy No: 07 Effective Date: January

More information

Becker Muscular Dystrophy

Becker Muscular Dystrophy Muscular Dystrophy A Case Study of Positional Cloning Described by Benjamin Duchenne (1868) X-linked recessive disease causing severe muscular degeneration. 100 % penetrance X d Y affected male Frequency

More information

Genetic analysis of Brugada syndrome and congenital long- QT syndrome type 3 in the Chinese

Genetic analysis of Brugada syndrome and congenital long- QT syndrome type 3 in the Chinese JCDR Original Paper Genetic analysis of Brugada syndrome and congenital long- QT syndrome type 3 in the Chinese Peng Liang, Wenling Liu 1, Cuilan Li 1, Wuhua Tao 2, Lei Li 1, Dayi Hu 1 Heart Center, Beijing

More information

DUKE EP SYMPOSIUM. Long QT Syndrome: Genotype- Phenotype Correlations

DUKE EP SYMPOSIUM. Long QT Syndrome: Genotype- Phenotype Correlations DUKE EP SYMPOSIUM Long QT Syndrome: Genotype- Phenotype Correlations Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Med Center Rochester, NY Cary, NC January 21, 2011 CONFLICT

More information

The Long-QT Syndrome: A Silent Killer

The Long-QT Syndrome: A Silent Killer The Long-QT Syndrome: A Silent Killer Claire Crowley CLINICAL POINTS The long-qt syndrome can be inherited or acquired. It affects the function of cardiac ion channels and is characterised by a prolonged

More information

Clinical Policy Title: Genetic Testing for Long QT Syndrome (LQTS)

Clinical Policy Title: Genetic Testing for Long QT Syndrome (LQTS) Clinical Policy Title: Genetic Testing for Long QT Syndrome (LQTS) Clinical Policy Number: (391) 04.01.02 Effective Date: Dec. 1, 2013 Initial Review Date: June 19, 2013 Most Recent Review Date: July 17,

More information

Long QT Syndrome: A Pamphlet for Community Awareness in Prevention of Sudden Cardiac Death in the Young

Long QT Syndrome: A Pamphlet for Community Awareness in Prevention of Sudden Cardiac Death in the Young Long QT Syndrome: A Pamphlet for Community Awareness in Prevention of Sudden Cardiac Death in the Young Bauke Pier Lettenga Helena Lustig Bachelor s Thesis November 2009 School of Health and Social Studies

More information

Genetic Testing for Long QT Syndrome

Genetic Testing for Long QT Syndrome Technology Evaluation Center Genetic Testing for Long QT Syndrome Assessment Program Volume 22, No. 9 February 2008 Executive Summary Background A genetic test is currently commercially available for mutations

More information

What Does It Mean to have a Gene?

What Does It Mean to have a Gene? CHAPTER 25 What Does It Mean to have a Gene? by Walter Allan, M.D. More than a year after we had sent the blood samples on Kara, Guerin, Tom and Maryann to Dr. Mark Keating s lab in Salt Lake City we still

More information

L ong QT syndrome causes sudden

L ong QT syndrome causes sudden LEADING ARTICLE 445 Cardiology... Is there a relation between SIDS and long QT syndrome? J R Skinner... A discussion of the evidence to date L ong QT syndrome causes sudden unexpected death through rapid

More information

Guidance for Industry

Guidance for Industry Guidance for Industry E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs U.S. Department of Health and Human Services Food and Drug Administration

More information

Epinephrine-Induced QT Interval Prolongation: A Gene-Specific Paradoxical Response in Congenital Long QT Syndrome

Epinephrine-Induced QT Interval Prolongation: A Gene-Specific Paradoxical Response in Congenital Long QT Syndrome Mayo Clin Proc, May 2002, Vol 77 Infusion QT Stress Testing in LQTS 413 Original rticle -Induced QT Interval Prolongation: Gene-Specific Paradoxical Response in Congenital Long QT Syndrome MICHEL J. CKERMN,

More information

www.irishheart.ie LONG QT SYNDROME SUPPORT GROUP IRELAND

www.irishheart.ie LONG QT SYNDROME SUPPORT GROUP IRELAND www.irishheart.ie LONG QT SYNDROME SUPPORT GROUP IRELAND Long QT Syndrome Support Group This is a voluntary group of people, all of whom have families with Long QT syndrome (LQTS). It was set up in association

More information

The functional characterisation of

The functional characterisation of Review Article Hellenic J Cardiol 2012; 53: 439-446 Effects of Mutations and Genetic Overlap in Inherited Long-QT and Brugada Arrhythmia Syndromes Christina-Maria Kotta, Aris Anastasakis, Christodoulos

More information

Pharmacology & Therapeutics

Pharmacology & Therapeutics Pharmacology & Therapeutics 131 (2011) 171 177 Contents lists available at ScienceDirect Pharmacology & Therapeutics journal homepage: www.elsevier.com/locate/pharmthera Associate Editor: O. Binah Pharmacological

More information

1 Mutation and Genetic Change

1 Mutation and Genetic Change CHAPTER 14 1 Mutation and Genetic Change SECTION Genes in Action KEY IDEAS As you read this section, keep these questions in mind: What is the origin of genetic differences among organisms? What kinds

More information

Equine Cardiovascular Disease

Equine Cardiovascular Disease Equine Cardiovascular Disease 3 rd most common cause of poor performance in athletic horses (after musculoskeletal and respiratory) Cardiac abnormalities are rare Clinical Signs: Poor performance/exercise

More information

Congenital long QT syndrome: Considerations for primary care physicians

Congenital long QT syndrome: Considerations for primary care physicians REVIEW CME CREDIT ETHAN LEVINE, DO Cardiology Division, Department of Medicine, University of Rochester Medical Center, Rochester, NY ARTHUR J. MOSS, MD Cardiology Division, Department of Medicine, University

More information

Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures.

Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures. Characterization of novel KCNH2 mutations in type 2 long QT syndrome manifesting as seizures. Dagmar Keller, Julie Grenier, Georges Christé, Frédérique Dubouloz, Stephan Osswald, Marijke Brink, Eckhard

More information

Over the past decade, the discovery of mutations in

Over the past decade, the discovery of mutations in Review Novel Insights in the Congenital Long QT Syndrome Xander H.T. Wehrens, MD; Marc A. Vos, PhD; Pieter A. Doevendans, MD; and Hein J.J. Wellens, MD Background: The congenital long QT syndrome is a

More information

Clinical Policy Title: Genetic Testing for Long QT Syndrome (LQTS)

Clinical Policy Title: Genetic Testing for Long QT Syndrome (LQTS) Clinical Policy Title: Genetic Testing for Long QT Syndrome (LQTS) Clinical Policy Number: 04.01.02 Effective Date: Dec. 1, 2013 Initial Review Date: June 19, 2013 Most Recent Review Date: July 15, 2015

More information

Potential Causes of Sudden Cardiac Arrest in Children

Potential Causes of Sudden Cardiac Arrest in Children Potential Causes of Sudden Cardiac Arrest in Children Project S.A.V.E. When sudden death occurs in children, adolescents and younger adults, heart abnormalities are likely causes. These conditions are

More information

Long QT Syndrome-associated Mutations in the Per-Arnt-Sim (PAS) Domain of HERG Potassium Channels Accelerate Channel Deactivation*

Long QT Syndrome-associated Mutations in the Per-Arnt-Sim (PAS) Domain of HERG Potassium Channels Accelerate Channel Deactivation* THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 274, No. 15, Issue of April 9, pp. 10113 10118, 1999 1999 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Long QT Syndrome-associated

More information

HIV, High Dose Methadone, and the Treatment Conundrum 5/8/2014. Frederick L. Altice, MD, MA

HIV, High Dose Methadone, and the Treatment Conundrum 5/8/2014. Frederick L. Altice, MD, MA EXPERT PANEL Managing HIV in Special Circumstances: Patients on High-Dose Methadone Frederick L. Altice, MD, MA Professor of Medicine, Epidemiology, and Public Health Yale University HIV, High Dose Methadone,

More information

Title: Genetics and Hearing Loss: Clinical and Molecular Characteristics

Title: Genetics and Hearing Loss: Clinical and Molecular Characteristics Session # : 46 Day/Time: Friday, May 1, 2015, 1:00 4:00 pm Title: Genetics and Hearing Loss: Clinical and Molecular Characteristics Presenter: Kathleen S. Arnos, PhD, Gallaudet University This presentation

More information

By the end of this continuing education module the clinician will be able to:

By the end of this continuing education module the clinician will be able to: EKG Interpretation WWW.RN.ORG Reviewed March, 2015, Expires April, 2017 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2015 RN.ORG, S.A., RN.ORG, LLC Developed

More information

Patient Information. for Childhood

Patient Information. for Childhood Patient Information Genetic Testing for Childhood Hearing Loss Introduction This document describes the most common genetic cause of childhood hearing loss and explains the role of genetic testing. Childhood

More information

Sudden unexplained death in infancy and long QT syndrome. Jonathan Robert Skinner

Sudden unexplained death in infancy and long QT syndrome. Jonathan Robert Skinner Sudden unexplained death in infancy and long QT syndrome. Jonathan Robert Skinner Greenlane Paediatric and Congenital Cardiac Services, Starship Children s Hospital, Park Road, Grafton, Auckland New Zealand.

More information

Lecture 3: Mutations

Lecture 3: Mutations Lecture 3: Mutations Recall that the flow of information within a cell involves the transcription of DNA to mrna and the translation of mrna to protein. Recall also, that the flow of information between

More information

Mutation-Specific Pharmacology of the Long QT Syndrome

Mutation-Specific Pharmacology of the Long QT Syndrome HEP (2006) 171:287 304 Springer-Verlag Berlin Heidelberg 2006 Mutation-Specific Pharmacology of the Long QT Syndrome R.S. Kass 1 ( ) A.J.Moss 2 1 Department of Pharmacology, Columbia University College

More information

Mendelian inheritance and the

Mendelian inheritance and the Mendelian inheritance and the most common genetic diseases Cornelia Schubert, MD, University of Goettingen, Dept. Human Genetics EUPRIM-Net course Genetics, Immunology and Breeding Mangement German Primate

More information

12-Lead EKG Interpretation. Judith M. Haluka BS, RCIS, EMT-P

12-Lead EKG Interpretation. Judith M. Haluka BS, RCIS, EMT-P 12-Lead EKG Interpretation Judith M. Haluka BS, RCIS, EMT-P ECG Grid Left to Right = Time/duration Vertical measure of voltage (amplitude) Expressed in mm P-Wave Depolarization of atrial muscle Low voltage

More information

Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs)

Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs) Lecture 6: Single nucleotide polymorphisms (SNPs) and Restriction Fragment Length Polymorphisms (RFLPs) Single nucleotide polymorphisms or SNPs (pronounced "snips") are DNA sequence variations that occur

More information

Assessment, diagnosis and specialist referral of adults (>16 years) with an episode of transient loss of consciousness (TLoC) or a blackout.

Assessment, diagnosis and specialist referral of adults (>16 years) with an episode of transient loss of consciousness (TLoC) or a blackout. Assessment, diagnosis and specialist referral of adults (>16 years) with an episode of transient loss of consciousness (TLoC) or a blackout. TLoC is common huge variation in management range of clinicians

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE Q5B INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE QUALITY OF BIOTECHNOLOGICAL PRODUCTS: ANALYSIS

More information

The P Wave: Indicator of Atrial Enlargement

The P Wave: Indicator of Atrial Enlargement Marquette University e-publications@marquette Physician Assistant Studies Faculty Research and Publications Health Sciences, College of 8-12-2010 The P Wave: Indicator of Atrial Enlargement Patrick Loftis

More information

This is the published version of a paper published in BMC Cardiovascular Disorders. Citation for the original published paper (version of record):

This is the published version of a paper published in BMC Cardiovascular Disorders. Citation for the original published paper (version of record): http://www.diva-portal.org This is the published version of a paper published in BMC Cardiovascular Disorders. Citation for the original published paper (version of record): Winbo, A., Stattin, E., Nordin,

More information

HLA-Cw*0602 associates with a twofold higher prevalence. of positive streptococcal throat swab at the onset of

HLA-Cw*0602 associates with a twofold higher prevalence. of positive streptococcal throat swab at the onset of 1 HLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control study Lotus Mallbris, MD, PhD, Katarina Wolk, MD, Fabio Sánchez

More information

Gene mutation and molecular medicine Chapter 15

Gene mutation and molecular medicine Chapter 15 Gene mutation and molecular medicine Chapter 15 Lecture Objectives What Are Mutations? How Are DNA Molecules and Mutations Analyzed? How Do Defective Proteins Lead to Diseases? What DNA Changes Lead to

More information

Wide-Complex Tachycardias in the ED: Myths and Pitfalls

Wide-Complex Tachycardias in the ED: Myths and Pitfalls Wide-Complex Tachycardias in the ED: Myths and Pitfalls, FACEP, FAAEM Professor and Vice Chair Director, Emergency Cardiology Fellowship Department of Emergency Medicine University of Maryland School of

More information

Genetics for preventative cardiology. Objectives HEART DISEASE COMES IN MANY FORMS!

Genetics for preventative cardiology. Objectives HEART DISEASE COMES IN MANY FORMS! Genetics for preventative cardiology Robert Nussbaum, MD Chief of Genomic Medicine, UCSF Medical Center; Co-Director, Program in Cardiovascular Genetics, UCSF Heart and Vascular Center Julianne Wojciak,

More information

trust clinical guideline

trust clinical guideline CG23 VERSION 1.0 1/7 Guideline ID CG23 Version 1.0 Title Approved by Transient Loss of Consciousness Clinical Effectiveness Group Date Issued 01/01/2013 Review Date 31/12/2016 Directorate Authorised Staff

More information

How do you decide on rate versus rhythm control?

How do you decide on rate versus rhythm control? Heart Rhythm Congress 2014 How do you decide on rate versus rhythm control? Dr Ed Duncan Consultant Cardiologist & Electrophysiologist Define Rhythm Control DC Cardioversion Pharmacological AFFIRM study

More information

Umm AL Qura University MUTATIONS. Dr Neda M Bogari

Umm AL Qura University MUTATIONS. Dr Neda M Bogari Umm AL Qura University MUTATIONS Dr Neda M Bogari CONTACTS www.bogari.net http://web.me.com/bogari/bogari.net/ From DNA to Mutations MUTATION Definition: Permanent change in nucleotide sequence. It can

More information

Introduction to Electrocardiography. The Genesis and Conduction of Cardiac Rhythm

Introduction to Electrocardiography. The Genesis and Conduction of Cardiac Rhythm Introduction to Electrocardiography Munther K. Homoud, M.D. Tufts-New England Medical Center Spring 2008 The Genesis and Conduction of Cardiac Rhythm Automaticity is the cardiac cell s ability to spontaneously

More information

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations & AF Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust Palpitations Frequent symptom Less than 50% associated with arrhythmia

More information

Ma et al. Stem Cell Research & Therapy (2015) 6:39 DOI 10.1186/s13287-015-0027-z

Ma et al. Stem Cell Research & Therapy (2015) 6:39 DOI 10.1186/s13287-015-0027-z Ma et al. Stem Cell Research & Therapy (2015) 6:39 DOI 10.1186/s13287-015-0027-z RESEARCH Open Access Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic

More information

Genetics Module B, Anchor 3

Genetics Module B, Anchor 3 Genetics Module B, Anchor 3 Key Concepts: - An individual s characteristics are determines by factors that are passed from one parental generation to the next. - During gamete formation, the alleles for

More information

MUTATION, DNA REPAIR AND CANCER

MUTATION, DNA REPAIR AND CANCER MUTATION, DNA REPAIR AND CANCER 1 Mutation A heritable change in the genetic material Essential to the continuity of life Source of variation for natural selection New mutations are more likely to be harmful

More information

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology

Atrial Fibrillation 2014 How to Treat How to Anticoagulate. Allan Anderson, MD, FACC, FAHA Division of Cardiology Atrial Fibrillation 2014 How to Treat How to Anticoagulate Allan Anderson, MD, FACC, FAHA Division of Cardiology Projection for Prevalence of Atrial Fibrillation: 5.6 Million by 2050 Projected number of

More information

Heritability: Twin Studies. Twin studies are often used to assess genetic effects on variation in a trait

Heritability: Twin Studies. Twin studies are often used to assess genetic effects on variation in a trait TWINS AND GENETICS TWINS Heritability: Twin Studies Twin studies are often used to assess genetic effects on variation in a trait Comparing MZ/DZ twins can give evidence for genetic and/or environmental

More information

Genetic Predisposition to Ventricular Arrhythmias and. Sudden Death in Hypertrophic Cardiomyopathy

Genetic Predisposition to Ventricular Arrhythmias and. Sudden Death in Hypertrophic Cardiomyopathy Dott.ssa Daria Santini Dottorato di Ricerca in Medicina Sperimentale Genetic Predisposition to Ventricular Arrhythmias and Sudden Death in Hypertrophic Cardiomyopathy Background Hypertrophic cardiomyopathy

More information

Anaesthesia recommendations for patients suffering from Long QT syndrome. Related syndromes: Romano-Ward S., Jervell and Lange-Nielsen S., Timothy S.

Anaesthesia recommendations for patients suffering from Long QT syndrome. Related syndromes: Romano-Ward S., Jervell and Lange-Nielsen S., Timothy S. orphananesthesia Anaesthesia recommendations for patients suffering from Long QT syndrome Disease name: Long QT syndrome ICD 10: I45.8 Synonyms: LQTS Related syndromes: Romano-Ward S., Jervell and Lange-Nielsen

More information

Next Generation Sequencing. mapping mutations in congenital heart disease

Next Generation Sequencing. mapping mutations in congenital heart disease Next Generation Sequencing mapping mutations in congenital heart disease AV Postma PhD Academic Medical Center Amsterdam, the Netherlands Overview talk Congenital heart disease and genetics Next generation

More information

FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies

FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies FSH Society s 2014 Biennial FSHD Connect Meeting: Natural History Studies Raymond A. Huml, MS, DVM, RAC Executive Director, Head, Global Biosimilars Business Development and Strategic Planning, Quintiles

More information

Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome

Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome Dysfunctional potassium channel subunit interaction as a novel mechanism of long QT syndrome Michael Hoosien, MD, * Mary Ellen Ahearn, MS, * Robert J. Myerburg, MD, * Thai V. Pham, PhD, y Todd E. Miller,

More information

Dental treatment of a patient with long QT syndrome under moderate sedation with target-controlled infusion of propofol

Dental treatment of a patient with long QT syndrome under moderate sedation with target-controlled infusion of propofol Case Report pissn 2383-9309 eissn 2383-9317 J Dent Anesth Pain Med 2015;15(3):161-165 http://dx.doi.org/10.17245/jdapm.2015.15.3.161 Dental treatment of a patient with long QT syndrome under moderate sedation

More information

Il loop recorder esterno. Roberto Maggi

Il loop recorder esterno. Roberto Maggi Il loop recorder esterno Roberto Maggi ECG monitoring and syncope In-hospital monitoring Holter Monitoring Event recorder External loop recorder Remote (at home) telemetry Implantable loop recorder External

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer Contents Introduction: biology and medicine, two separated compartments What we need to know: - boring basics in DNA/RNA structure and overview of particular aspects of molecular biology techniques - How

More information